186 results on '"Meduri, Gianfranco Umberto"'
Search Results
2. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
3. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
4. Diagnostic workup for ARDS patients
5. Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
6. Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
7. Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
8. Corticosteroids in pediatric ARDS: all cards on the table
9. General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections
10. Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
11. Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock
12. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)
13. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
14. Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
15. Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
16. Understanding ARDS-associated fibroproliferation
17. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
18. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment
19. POINT: Should Corticosteroids Be Routine Treatment in Early ARDS? Yes
20. Rebuttal From Drs Meduri and Rochwerg
21. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations
22. Reply to Ñamendys-Silva and Salluh
23. Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment
24. There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS
25. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
26. Novel Polymorphisms in the Myosin Light Chain Kinase Gene Confer Risk for Acute Lung Injury
27. Miscellaneous III
28. Noninvasive Positive-Pressure Ventilation vs Conventional Oxygen Supplementation in Hypoxemic Patients Undergoing Diagnostic Bronchoscopy*
29. Noninvasive Ventilation for Treatment of Acute Respiratory Failure in Patients Undergoing Solid Organ Transplantation: A Randomized Trial
30. Noninvasive Positive-Pressure Ventilation Via Face Mask During Bronchoscopy With BAL in High-Risk Hypoxemic Patients*
31. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids
32. Ventilator-associated pneumonia in patients with respiratory failure: a diagnostic approach
33. General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.
34. Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A Narrative Review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)
35. Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
36. Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
37. Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
38. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.
39. 80. Meduri GU. Why research with improved outcome was blocked by institutions created to protect research and public? Who enforces regulatory compliance to protect rights of patients, accused, and interests of society?
40. Exaggerated plasma Interleukin 6, Interleukin 10, and Subsequent Development of Health Care–Associated Infections in Patients With Sepsis
41. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment
42. H1N1 INFLUENZA: A VIRUS-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME: RESPONSE TO COMBINATION OSELTAMIVIR AND PROLONGED CORTICOSTEROID TREATMENT
43. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome*
44. Glucocorticoids and Inflammation Revisited: The State of the Art
45. A Comparison of Noninvasive Positive-Pressure Ventilation and Conventional Mechanical Ventilation in Patients with Acute Respiratory Failure
46. Noninvasive Positive−Pressure Ventilation Via Face Mask During Bronchoscopy With BAL in High−Risk Hypoxemic Patients
47. DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA
48. Bilateral Bronchoalveolar Lavage in the Diagnosis of Opportunistic Pulmonary Infections
49. Noninvasive Face Mask Mechanical Ventilation in Patients with Acute Hypercapnic Respiratory Failure
50. Novel Polymorphisms in the Myosin Light Chain Kinase Gene Confer Risk for Acute Lung Injury.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.